ANKTESIS Trademark

Trademark Overview


On Thursday, November 21, 2024, a trademark application was filed for ANKTESIS with the United States Patent and Trademark Office. The USPTO has given the ANKTESIS trademark a serial number of 98865900. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 28, 2025. This trademark is owned by ImmunityBio, Inc.. The ANKTESIS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services; medical information; providing a website featuring medical information in the fields of immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases; providing medical information relating to immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases

Biological and pharmaceutical cell preparations for medical use in cell therapy for the treatment and prevention of oncologic diseases and disorders, immune-oncologic diseases and disorders, cancer, non-cancerous neoplasia, immunologic dysfunction, immunologic-related diseases, infections, and infectious diseases
anktesis

General Information


Serial Number98865900
Word MarkANKTESIS
Filing DateThursday, November 21, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements


Goods and ServicesMedical services; medical information; providing a website featuring medical information in the fields of immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases; providing medical information relating to immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases
Goods and ServicesBiological and pharmaceutical cell preparations for medical use in cell therapy for the treatment and prevention of oncologic diseases and disorders, immune-oncologic diseases and disorders, cancer, non-cancerous neoplasia, immunologic dysfunction, immunologic-related diseases, infections, and infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, November 21, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 15, 2025ASSIGNED TO EXAMINER
Thursday, May 15, 2025PRIORITY ACTION WRITTEN
Thursday, May 15, 2025PRIORITY ACTION E-MAILED
Thursday, May 15, 2025NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, August 4, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, August 4, 2025EXAMINERS AMENDMENT E-MAILED
Monday, August 4, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 4, 2025EXAMINER'S AMENDMENT ENTERED
Monday, August 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 28, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT